Level Biotechnology Inc. (TPEX:3118)
Taiwan · Delayed Price · Currency is TWD 30.60
-0.05 (-0.16%)
Oct 30, 2026, 12:09 PM CST
Level Biotechnology Market Cap
Level Biotechnology has a market cap or net worth of 993.06 million as of October 30, 2026. It is the 33,765th most valuable company in the world and the 2,035th biggest in Taiwan. Its market cap has decreased by 9.87% in one year.
Market Cap
993.06M
Enterprise Value
805.06M
Revenue
709.37M
Global Rank
Country Rank
#2,035 Taiwan
PE Ratio
13.13
ChartMarket Cap Chart
Since November 3, 2004, Level Biotechnology's market cap has increased from 249.68M to 993.06M, an increase of 297.73%. That is a compound annual growth rate of 6.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 993.06M | -7.27% |
| Dec 31, 2025 | 1.07B | 3.13% |
| Dec 31, 2024 | 1.04B | 5.09% |
| Dec 29, 2023 | 988.19M | 10.13% |
| Dec 30, 2022 | 897.32M | -7.68% |
| Dec 30, 2021 | 971.96M | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abnova (Taiwan) | 1.25B |
| NeoCore Technology | 1.22B |
| LabTurbo Biotech | 1.11B |
| Bio Preventive Medicine | 1.09B |
| BiOptic | 992.66M |
| Holy Stone Healthcare | 992.62M |
| TCI GENE | 952.51M |
| GeneReach Biotechnology | 949.53M |